| (SEK) | Sep 2023 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 28.62M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SPRINT.ST returned +426.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +114.3% |
| 1 year | +426.8% |
| 5 years | -31.2% |
| 10 years | -88.6% |
| All-time high | kr 43.08 (May 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in SPRINT.ST would be worth today ›No. Sprint Bioscience AB (publ) has not paid a dividend in the past 12 months.
Sprint Bioscience AB (publ) is part of the Healthcare sector.
Sprint Bioscience AB (publ) has a market cap of 332.37M SEK, based on the latest quote.
